Propyl (2E,4Z)-2,4-decadienoate
Common Name: |
Propyl (2E,4Z)-2,4-decadienoate |
IUPAC Name: |
propyl (2E,4Z)-deca-2,4-dienoate |
Molecular Formula: |
C13H22O2 |
SMILES: |
CCCCCC=CC=CC(=O)OCCC |
Inchi: |
1S/C13H22O2/c1-3-5-6-7-8-9-10-11-13(14)15-12-4-2/h8-11H,3-7,12H2,1-2H3/b9-8-,11-10+ |
Inchi Key: |
RKDOXCGYGLYOBV-QNRZBPGKSA-N |
Cas No: |
28316-62-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
210.31 |
Mass (g/mol) |
210.162 |
Molar Refractivity |
64.94 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
9 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
276.00 to 278.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
3.632 |
iLOGP |
3.67 |
XLOGP3 |
4.53 |
WLOGP |
3.63 |
MLOGP |
3.22 |
ESOL Log S |
-3.40 |
ESOL Solubility (mg/ml) |
0.083 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.80 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.96 |
Silicos-IT Solubility (mg/ml) |
0.23 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.37 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.925 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.831 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |